Combination of Captopril and Allopurinol Retards Fructose-Induced Metabolic Syndrome | Zendy

Carmen Roncal | Zendy; Sirirat Reungjui | Zendy; Laura Gabriela SánchezLozada | Zendy; Wei Mu | Zendy; Yuri Y. Sautin | Zendy; Takahiko Nakagawa | Zendy; Richard J. Johnson | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Combination of Captopril and Allopurinol Retards Fructose-Induced Metabolic Syndrome

Author(s) -

Carmen Roncal,

Sirirat Reungjui,

Laura Gabriela SánchezLozada,

Wei Mu,

Yuri Y. Sautin,

Takahiko Nakagawa,

Richard J. Johnson

Publication year - 2009

Publication title -

american journal of nephrology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.394

H-Index - 85

eISSN - 1421-9670

pISSN - 0250-8095

DOI - 10.1159/000235731

Subject(s) - medicine , allopurinol , metabolic syndrome , endocrinology , hyperuricemia , insulin resistance , fenofibrate , dyslipidemia , hypertriglyceridemia , hyperinsulinemia , captopril , fructose , type 2 diabetes , diabetes mellitus , blood pressure , uric acid , cholesterol , triglyceride , biology , biochemistry

Both ACE inhibitors and allopurinol have been shown to partially prevent metabolic syndrome induced by fructose. We tested the hypothesis that combined therapy might be more effective at blocking the metabolic syndrome induced with fructose.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research